Motivation: Finding driver genes that are responsible for the aberrant proliferation rate of cancer cells is informative for both cancer research and the development of targeted drugs. The established experimental and computational methods are labor-intensive. To make algorithms feasible in real clinical settings, methods that can predict driver genes using less experimental data are urgently needed. Results: We designed an effective feature selection method and used Support Vector Machines (SVM) to predict the essentiality of the potential driver genes in cancer cell lines with only 10 genes as features. The accuracy of our predictions was the highest in the Broad-DREAM Gene Essentiality Prediction Challenge. We also found a set of genes whose essentiality could be predicted much more accurately than others, which we called Accurately Predicted (AP) genes. Our method can serve as a new way of assessing the essentiality of genes in cancer cells.
Introduction
Cancers result from the mutations accumulated during the lifetime of the patients and are characterized by fast and uncontrollable cell proliferation. These mutations can be sub-classified as either driver mutations or passenger mutations (Stratton et al., 2009; Vogelstein et al., 2013) . Finding cancer driver mutations that are responsible for the aberrant proliferation rate of cancer cells is informative for both cancer research and the development of targeted drugs. One of the frequently used approaches is loss-of-function screening (Cowley et al., 2014) where the cancer cells are infected with a large pool of shRNAs. Driver genes can thus be identified according to the changes in the proliferation rate of cancer cells. However, due to the limitation in time and resources, it is impractical to use wholegenome RNAi screening as a routine diagnostic test for patients. More practical ways of finding sample-specific driver genes are needed. So far, various in silico driver gene discovery methods have been published, such as Helios (Sanchez-Garcia et al., 2014) , CHASM (Carter et al., 2009) and OncoIMPACT (Bertrand et al., 2015) . These powerful algorithms share a common overlooked limitation, which is the overwhelming model complexity. Most methods are using a staggering number of experimental observations as features to make predictions, which hinders their application in real clinical settings. An algorithm that is able to use a small set of features to make sample-specific cancer driver gene prediction is urgently needed.
The Broad-DREAM Gene Essentiality Prediction Challenge (https://www.synapse.org/#! Synapse: syn2384331/wiki/) was coorganized by the Broad institute, the DREAM Initiative and SAGE Bio-networks. It aimed to gather researchers in bioinformatics and biomedical informatics to advance the methods of discovering driver genes for cancer cells and provide insights for the development of targeted cancer therapies. This challenge provided a large-scale genomewide RNAi-mediated cancer cell line screen dataset (Cowley et al., 2014) and asked the participants to design novel algorithms to predict the essentiality of genes in cancer cell lines. Here, gene essentiality (or dependency) refers to the importance of a given gene for the proliferation of a given cancer cell line. The gene expression and copy number profiles of the cell lines were provided by Broad-Novartis Cancer Cell Line Encyclopedia (CCLE) (Barretina et al., 2012) for feature construction. The sub-challenge 2 (SC2) of the DREAM competition asked the participants to use no >10 features for essentiality prediction. We developed an effective machine learning algorithm that makes cell line-level gene essentiality prediction with only 10 features, and won the first place in SC2 of the DREAM competition. We designed an innovative feature selection method and employed support vector machine (SVM) as the base learner. The feature selection procedure leveraged the correlation between the predictors and the gene essentiality on two complementary scales (global and local scale). Eventually, nine most predictive gene expression features and one copy number feature were selected specifically for each potential cancer driver gene. We found that many previously confirmed biomarkers were re-identified by our method, which supports the biological significance of our feature selection method. The algorithm presented in this manuscript has the potential to serve as a new way of assessing the essentiality of genes in cancers.
Materials and methods

Data acquisition
Gene essentiality scores of 14 738 genes in 105 human cancer cell lines were provided by Project Achilles, and were downloaded from the DREAM challenge website. The essentiality scores were obtained with a genome-wide loss-of-function shRNA screening assay (Cowley et al., 2014) . First, $98 000 shRNAs targeting $17 000 genes were lentivirally delivered to cancer cells at an MOI (Multiplicity of Infection) of 0.3. Each cell would receive either zero or one shRNA. Cells were harvested after 16 population doublings or 40 days in culture, whichever came first. The essentiality of genes was measured by the relative abundance of shRNA in these cells with regard to the initial shRNA pool using next generation sequencing (NGS) technology. The raw read counts obtained by NGS were first normalized with the following function:
where R is the raw read count for each shRNA and T is the total raw read counts.
Then, the normalized read counts were log2 transformed:
Quality control was performed on the normalized and transformed read counts using GenePattern module (Reich et al., 2006) , which enabled the removal of overlapped shRNAs and shRNAs that had low abundance in DNA reference. GenePattern module was then used to calculate an shRNA-level score for each cell line, and map shRNAs to genes. DEMETER (Tsherniak et al., 2017) was used to calculate a gene-level essentiality score (ES) for each cell line. DEMETER decomposes the effect of an shRNA into a linear combination of the gene effect (on-target effect) and seed effect (offtarget effect). The essentiality score, which is a unit-free coefficient in the model, represents the relative strength of the on-target effect. For a given gene, ES¼ Àk(negative) means the essentiality is k standard deviations more dependent than the average essentiality in all cell lines, while positive ES scores indicate lower-than-average essentiality. In sum, lower ES indicate higher essentiality ( Supplementary  Fig. S1A ).
Gene expression levels of 18 960 genes (CCLE-EXP genes) and copy number profiles of 23 288 genes (CCLE-CN genes) in 149 cell lines (105 training, 44 testing) were provided by CCLE and downloaded from the DREAM challenge website. The DNA copy numbers were measured by a genome-wide human Affymetrix SNP array 6.0. The mRNA expression levels were measured using Affymetrix Human Genome U133 Plus 2.0 arrays. The raw data were processed as described in a previously published paper (Barretina et al., 2012) . A gene list containing 2647 prioritized genes (PR genes) was downloaded from the DREAM challenge website. The prioritized gene list overlapped with CCLE-EXP genes and CCLE-CN genes but was not a subset of them. In other words, not all PR genes had available expression data or copy number data. The PR gene list was a subset of Achilles genes, which in other words means every PR gene had available Achilles gene essentiality scores in the 105 training cell lines. The essentiality scores of PR genes in the 44 testing cell lines are hidden at the model development stage. A detailed description of the DREAM challenge and the generation of the aforementioned datasets is available online at https://www.synapse.org/#! Synapse: syn2384331/wiki/62826. The community-authored summary has been published (Cell Systems, Nov 2017).
Selection of ten predictors
The expression features were selected as shown in Figure 1 . First, the Pearson correlation coefficients between the Achilles essentiality scores of every PR gene and expression levels of every CCLE-EXP gene were calculated using the canonical function:
Pearson correlation score ¼ covarianceðx; yÞ deviationðxÞ Â deviationðyÞ (3) where vector x is the expression levels of a CCLE-EXP gene in all training cell lines, and vector y is the essentiality scores of a certain PR gene in all training cell lines. Thus, the total number of Pearson correlation scores is:
18 960 CCLE EXP genes ð Þ Â 2647 PR genes ð Þ ¼ 50 187 120 Pearson correlation scores ð Þ
These scores measured the significance of the correlation between the expression levels of CCLE-EXP genes and the essentiality scores of PR genes. We named them local scores as they represented 1 versus 1 association between each feature and target pair. Then we calculated global scores as a complement to the local scores to represent the correlation between a certain CCLE-EXP gene and all PR genes (1 versus all association). To obtain the global scores, first we ranked CCLE-EXP genes according to their local scores for each PR gene. Then we counted how many times a CCLE-EXP gene appears in top 10 of the ranked local scores. The cutoff '10' was decided empirically. This yielded 18 960 non-negative integers which were 2647. These numbers were used to calculate the global scores using the following formula.
Global scores ¼ count of occurrence in top 10 maxfcount of occurrence in top 10g
Here the denominator is a constant and can be viewed as a scaling factor ( Supplementary Fig. S1B ). The global scores are thus all on the scale of 0 to 1. The local scores range from À1 to 1. Local scores are different for each CCLE-EXP & PR gene pair. Global score is a length of 18 960 vector corresponding to the CCLE-EXP genes, or, in other words, a rank-one matrix corresponding to the CCLE-EXP & PR gene pairs. To combine the global and local correlation information, we calculated the weighted average of the global and local scores using the following formula, and optimized the weight (a) via cross-validation. This naive formula is chosen to avoid heavy calculation process. It is also a common practice in machine learning to use weighted averages to mix information coming from different resources.
Combined correlation score ¼ 1 À a ð ÞÂlocal scoreðx; yÞ þ a Â global scoreðxÞ (6) i.e. for each PR gene y, we give a local score of local (x, y) for the correlation with the PR gene and a global score for x, for the global frequency of this feature over all PR genes. The alpha score is determined through a grid search ( Supplementary Fig. S3 ) in crossvalidation, and reflects the relative importance of the local model and the global model. The CCLE-EXP genes that have the nine largest combined correlation scores were then included as predictive features. If the copy number of the PR gene itself is available, it will be selected as the 10th feature; if the copy number was not available, we use expression data of the top 10 CCLE-EXP genes as 10 predictive features.
Build the gene-specific prediction model
We built gene-specific models so that each model predicts essentiality scores for one specific PR gene in all testing cell lines ( Supplementary Fig. S2 ). The target values are Achilles gene essentiality scores of all PR genes in the training cell lines. The essentiality scores were first normalized for each PR gene using the following formula:
Scaled Score ¼ Original Score À min max À min (7) where min is the minimum Achilles score for a PR gene, and max is the maximum Achilles score for a PR gene. After scaling, all essentiality scores fall in the range 0-1, and the maximum essentiality scores for all PR genes are shifted to 1. The features in the input data were expression levels of nine CCLE-EXP genes, plus the copy number of the interested PR gene in each of 105 cell lines. The input file for each PR gene was a 105 ðtra ining cell linesÞ Â ð10 featuresÞ matrix targeting to predict the gene essentiality score. Similarly, the testing data for each PR gene was a 44 ðtesting cell linesÞ Â ð10 featuresÞ matrix. The models were then used to make predictions for the essentiality scores of PR genes in the testing cell lines.
To avoid overfitting, we used repeated 5-fold cross-validation (CV) to optimize our model. In each round of CV, the whole dataset was evenly divided into five parts (i.e. 21 cell lines each). We iteratively withheld one part of the dataset, used the remaining four parts to train our regression model and made predictions on the withheld data. The test was repeated five times to reduce the variance of our performance estimation. After we obtained the predicted gene essentiality scores, Spearman coefficients between the predicted scores and the Achilles essentiality scores of the 2647 PR genes in 21 cell lines were calculated. The mean of 2647 Spearman scores was calculated, which would be the performance of a single round of crossvalidation. As described before, we performed five rounds of 5-fold validation; thus, in total we got 5 Â 5 ¼ 25 scores. The performance of the current model was represented by the mean of these 25 scores.
Results
Searching predictive features by leveraging the global and local prediction power
In the gene essentiality DREAM challenge, we developed a model to predict the essentiality scores of 2647 prioritized genes (PR genes) in 44 testing cell lines. The training data comprise the Achilles gene essentiality scores of the 2647 PR genes in 105 cell lines (Fig. 1) . The predictors in the model were constructed from the gene expression profiles and copy number profiles of the 105 cell lines.
To simplify feature space while maintaining the prediction power, we selected 10 most predictive features for each PR gene. The top nine CCLE-EXP genes whose expression levels were in strong correlation with the Achilles essentiality scores of PR genes were selected as predictive features. The strength of the correlations was measured by the combined correlation scores which were the weighted summation of global scores and local scores. The weights assigned to global and local scores were controlled by the parameter a. After cross validation, 0.7 is selected as the optimal value for a (CV results shown in Supplementary Fig. S3A ). The CV results confirmed that a combination of the information from two scales (global/local) has more predictive power than any individual scale. The global scores represent the relative frequency of having a high local Fig. 1 . Method pipeline. In training datasets, the known information included gene expression levels, copy number profile and Achilles essentiality scores of the prioritized genes in the training cell lines. After feature selection, 10 features, including nine expression features and one copy number feature, were selected for each prioritized gene. Then SVM was performed to build genespecific models using only 10 features. These gene-specific models were then used to predict the essentiality of genes in the training cancer cell lines score and can be viewed as a correction parameter for local scores that introduces generalizability. On the other hand, local scores add specificity to global scores.
Apart from expression features, we used the copy number of the PR gene itself as the 10th feature. However, not all PR genes had available copy number profile. In these cases, we used top 10 instead of top nine CCLE-EXP genes as predictive features. These 10 features were then used to build models for each PR gene. We compared the performance of five alternative machine learning algorithms using 5-fold cross-validation (CV results shown in Supplementary Fig. S3B ), and chose support vector machine (SVM), which performed best as the base learner.
3.2 Accurately predicted (AP) genes are top 50 most accurately predicted PR genes Figure 2A shows the distribution of the Spearman correlation coefficients between the predicted and the observed Achilles essentiality scores of 2647 PR genes in 44 testing cell lines. The mean Spearman correlation was $0.201 (see Supplementary Table S1 for all scores). Figure 2B shows the performance of our methods in individual cancer cell lines (see Supplementary Table S2 for all scores). The cell lines that had the best prediction performance were SUDHL4 (diffuse B-cell lymphoma cell line) and MELHO (melanoma cell lines). On the other hand, some cell lines were predicted with suboptimal accuracy, which indicates that these cell lines might need further exploration.
In view of the complexity of biological processes and the diverse characters and functions of genes, we are not expecting to obtain equal prediction accuracy for all potential driver genes. Indeed, some PR genes were predicted with extraordinary accuracy. The top three most accurately predicted genes are PSMD2 (mean correlations ¼ 0.771), SF3B3 (mean correlations ¼ 0.756) and SF3A1 (mean correlations ¼ 0.771) (see Fig. 2C and Supplementary Fig. S4 ). We define genes with top 50 Spearman correlations as Accurately Predicted (AP) genes. We investigated the cause of the varied prediction performance of AP genes compared with non-AP genes (genes not among the top 50) from several aspects.
3.3 AP genes were connected with more genes in the functional network, and were associated with protein and RNA processing GO terms
We used the human genome-scale gene functional network published by Li et al. to investigate the functional connection between AP genes and their related genes (H.-D. . This is an isoform-level network built using multiple instance learning (MIL). This gene network integrated isoform-level features and gene-level annotations and is able to show functional associations between pairs of genes. Specifically, this network captures the information of how likely two genes function in the same biological pathway, by integrating large-scale co-expression datasets, protein-protein physical interactions, shared motifs and domains through a Bayesian integration framework, and trained on shared pathways or GO terms. The end result of this network is a connected graph between two genes in the system, where a connection indicates that two genes cofunction. As shown in Figure 3A , genes with higher Spearman correlation coefficients tended to have more neighbors in the network. On average, each AP gene had 402.96 neighbors in the network, while the average number of neighbors for all PR genes was 186.19. The reason accounting for the difficulty in predicting genes with fewer neighbors might be that the functions of these genes could not be revealed by the expression level of other genes. Figure 3B is the functional network of the top five PR genes. This network showed that more accurately predicted genes had more neighbors and the top genes had many neighbors in common. These genes could be functionally related to each other. Figure 4A shows the Pearson correlation scores between AP genes and a union of their features. Some genes share similar patterns, i.e. they were highly correlated with the same group of features. This means those genes could share certain pathways.
After performing GO enrichment on AP genes using DAVID (Huang et al., 2009a, b) , we found these genes were associated with RNA processing and protein processing GO terms (Fig. 4B) . Examples for RNA processing were 'mRNA processing', 'mRNA splicing', 'Spliceosome'. Examples for protein processing were 'proteasome', 'proteasome accessory complex'. We then compared the AP genes and a list of human housekeeping genes (Supplementary Table S1 ). These housekeeping genes are inferred by a Bayesian classifier based on 68 microarray screens in human cell lines (Hart et al., 2014) . We found that 37/50 (74%) AP genes are housekeeping genes; There exists a significant difference in the Spearman correlations between housekeeping PR genes and non-housekeeping PR genes (t-test P-value < 2.2e-16) ( Supplementary Fig. S5 ). The housekeeping genes are significantly more accurately predicted.
These results partially explained the high performance of the AP genes. Top genes are associated protein processing and RNA processing related GO terms, and many of them appeared to be essential (housekeeping) across cell lines. Therefore, their function affects a numerous number of genes and proteins, and the activity of these genes could be uncovered by the expression levels of other genes, which made them more accurately predicted.
We also performed GO enrichment using DAVID on top 50 most frequent features ( Supplementary Fig. S6A ). Many of the enriched GO terms were related to cell adhesion and transmembrane signal transduction.
Copy number data complements the prediction power of gene expression data in predicting gene essentiality
As shown in Figure 5A , we tested four different combinations of expression features and copy number features:
1. The first method ranked all expression features by the combined correlation scores, then picked up top 10 as the predictive features. 2. The second method ranked all expression features by the combined correlation scores, then used top nine expression features plus the copy number feature of the PR gene itself (if available) as 10 predictive features.
3. The third method pooled the expression data and copy number data together, resulting in a list of mixed features. Then the local scores, global scores and combined correlation scores were calculated in the same way as mentioned above. After ranking the mixed features by combined correlation scores, we chose the top 10 features in this ranked list as predictive features. The second method outperformed the others, which proved that adding copy number information of the PR gene itself could improve the prediction performance, but adding copy number of other genes would have the opposite effect. In our experiment, the number of features is overwhelmingly large compared to the number of examples. A traditional feature selection scheme will inevitably lead to selection of noisy features that happen to/coincidentally correlate with the outcome. The selection of self-CNV is, instead, guided more by biological insight than a purely data-driven approach. This insight is that the copy number of a gene itself will greatly affect the result when the gene is targeted or is to be suppressed. The known relationship between cancers and copy number alteration (CNA) can explain the prediction power of the copy number of the PR gene itself. CNAs frequently appear in cancer cells and are believed to contribute to the progression of cancers (Bowcock, 2014) , because regions subjected to copy number change could harbor key genes that have the potential to trigger the development or change the characteristics of cancers. HER2-positive breast cancer is breast cancer with overexpressed HER2 protein or amplified HER2 gene (Ng et al., 2015; Lee et al., 2014; Slamon et al., 1987) . For HER2-positive breast cancers, targeting HER2 will make a significant change to the proliferation of cancer cells, which implies that the essentiality of HER2 is high. Meanwhile, the essentiality of HER2 is lower for HER2-negative individuals. Therefore, it is reasonable to assume the non-random co-occurrence of high/low gene essentiality and different patterns of copy numbers. This non-random co-occurrence between the feature and the gold standard is a potential reason that explains the predictive power of copy number features. Using copy number data of other genes did not result in better performance. This is probably because the copy number change of a certain gene is often accompanied by the copy number change of other genes especially its flanking genes because the genome of the cancer cells is fragile and unstable (Nijhawan et al., 2012) . The copy number features are therefore prone to false positive choices.
Previously confirmed cancers biomarkers were picked out by the feature selection method
After feature selection, each PR gene was assigned 10 predictive features (see Supplementary Table S3 for the predictive features of all PR genes). We ranked the expression features with respect to how many times each was among 10 predictive features (Supplementary  Table S4 ). We found most of the top features were genes previously identified as cancer biomarkers (Table 1) . BCL9L (B-cell CLL/ lymphoma 9-like, BCL9-2) was predictive for 650/2647 genes (24.6%) and has been associated with a variety of human cancers, such as colon, pancreatic (Sannino et al., 2016a) , leukemia (Sannino et al., 2016b) , intestinal (Zatula et al., 2014) and breast (Zatula et al., 2014) . PTPRF was predictive for 628/2647 genes (23.7%). PTPN12 ranked right after PTPRF for being predictive for 503/ 2647 gene ($19%). PTPN12 and PTPRF are both members of the protein tyrosine phosphatases (PTPs) family. Proteins of this family have key roles in many biological processes including cell proliferation, migration and differentiation . Various studies proved that the aberration of PTPRF is associated with tumorigenesis and malignancy (Soulières et al., 2015) . PTPN12 is known for playing vital roles in cell migration and adhesion (Luo et al., 2014) and has important roles in ovarian (Villa-Moruzzi, 2011 , hepatocellular (Luo et al., 2014) and breast cancers and is a potential therapeutic biomarker (Harris et al., 2014; Tonks, 2006) . In addition to the above-mentioned genes, other top features are potential biomarkers or tumor suppressors (Table 1 ). This result showed that our feature selection process was efficient in detecting predictive biomarkers.
The first column is the gene symbol of the CCLE-EXP gene. The second column is the number of PR genes that those features were predictive for. The percentage is second column/total*100%. The third column listed a few cancers that were shown in published studies to be closely related to the CCLE-EXP genes.
Prediction accuracy of ten features resembled that of the whole feature set
We tested the prediction performance of different numbers of features using 5-fold cross-validation (Fig. 5B) . The alternative numbers we tested ranged from 3 to 18 960, which is the total number of expression features. The performance kept increasing at the beginning, but the increasing rate of performance became much slower as more features were added. Three features and 10 features performed significantly different (t-test P-value ¼ 0.0001689), but the difference between using 10 features and 18 960 features was not statistically significant (t-test P-value ¼ 0.08603). It is also worth noting that the difference between 5 and 10 features was not statistically significant (t-test P-value ¼ 0.09318). This showed the possibility that fewer features can be used while still capable of capturing most of the information and getting reasonable prediction accuracy. Most importantly, the computational time, in terms of linear SVM, grows linearly with the number of examples and a subset of 10 genes has great advantage over the whole $20 000 gene features from a model construction perspective.
Most expression features are only predictive for a small set of PR genes
We counted the occurrence of each expression feature in 10 predictive features and found that some expression features appear to be predictive for as many as $25% of PR genes (Table 1) , such as ASAP2 ($26.3%), BCL9L ($24.6%) and PTPRF ($23.7%). (Bera et al., 2014; Liu et al., 2015; Soulières et al., 2015) , prostate cancer (Trojan et al., 2005) , colorectal cancer (Bera et al., 2014; Bujko et al., 2015) , gastric cancer, hepatocellular carcinoma (Soulières et al., 2015) PTPN12 503 (19.0%) Breast cancer (Harris et al., 2014; Luo et al., 2014; Tonks, 2006) , hepatocellular carcinoma (Luo et al., 2014) , ovarian cancer (Villa-Moruzzi, 2013 , 2011 Bladder cancer (Yu et al., 2014) Bladder carcinoma (Zhang et al., 2015) , colon cancer (Li et al., 2010) , myeloma (Zhou et al., 2010) Most expression features which appeared at least once in 10 predictive features were only predictive for a very small set of genes; 49.4% of all predictive expression features only appeared once. $90% of all predictive features were predictive for no >$1.5% of all PR genes. Therefore, features were usually not globally predictive. The vast majority of features were specifically associated with a very small set of PR genes. Some features had very special patterns of ranking ( Fig. 5C and Supplementary Fig. S6B ). For example, PTPRF was selected as predictive features for 628 genes and its combined correlation scores all ranked top two in those 628 genes. EIF2C2 appeared 395 times in 10 predictive features, and 91.65% of the time it ranked #1. In contrast, for PTPN12 the rankings were more evenly distributed (#1: 6.36%, #2: 8.55%, #3: 13.72%, #4: 10.93% and so on). We noticed that those features such as PTPRF and EIF2C2 had very few neighbors in the functional network. PTPRF had only 30 nearest neighbors. EIF2C2 and BCL9L had no neighbors under our criteria (though EIF2C2 and BCL9L do interact with numerous genes). In contrast, FH had 839 neighbors and CPOX had 215 neighbors. This raises the possibility that features with fewer neighbors had higher rankings due to the reason that the network it is involved in is small and all the genes in this network are strongly associated with each other, so the feature is highly predictive for those genes involved in that network. Another reason could be that they were associated with RNA and protein processing functions. For example, EIF2C2 encodes AGO2 (Argonaute-2) which is expressed ubiquitously in most parts of the body and plays a key role in RNA interference (Meister, 2013) and DNA repair (Ye et al., 2015) . Thus, the expression levels of such genes could affect or be affected by a large set of genes. This could result in a relatively high global score. As our model puts more weight to global scores than local scores (7:3), those genes were more likely to have higher rankings.
Discussion
We developed a model that used the gene expression and copy number profiles of cancer cells to predict the essentiality of a list of genes. The accuracy of our prediction was measured by the Spearman correlations between the predicted scores and the Achilles gene essentiality scores. The Achilles essentiality scores of genes in cancer cells were measured by the influence of genes on the proliferation rate of the cancer cells. The essentiality scores were provided by Project Achilles. The expression and copy number profiles were provided by CCLE. We selected 10 features from over 40 000 expression/copy number features to predict the essentiality of a set of prioritized genes in cancer cells. The 10 predictive features were composed of nine expression features and one copy number feature.
We defined top 50 most accurately predicted PR genes as Accurately Predicted (AP) genes. These genes' essentiality could be accurately predicted from expression and copy number features that we selected. The evaluation of our method was done in 44 testing cancer cell lines, and as shown in Figure 2C there were no extreme values or outliers. These facts indicated that the prediction accuracy of AP genes was genuinely stable in different cancer cell lines. Some of the AP genes and other accurately predicted genes are identified as housekeeping genes. We further investigated the genes which are non-housekeeping but still accurately predicted, and found that those genes are likely to be cancer-specific essential genes. POLD1, a non-housekeeping gene, has a Spearman score of 0.66. It was associated with colorectal cancers (Palles et al., 2013) . TP53 is a wellknown non-housekeeping oncogene that is accurately predicted with a score of 0.62. This shows the exciting prospect that the top predicted genes (including AP genes) can be future research subjects, as they are potential cancer specific essential/housekeeping genes.
In this study, the features we selected were solely used as biomarkers for gene essentiality, but, as shown above, many previously discovered cancer biomarkers appeared in our top feature list. There were still some top features for which we could not confirm their relationship with cancers. Those genes might have vital roles in cancer cells that worth further exploration. In the feature selection procedure, we gave a higher weight to global scores (0.7) than local scores (0.3). However, as these two scores are on different scales (global scores 2 ½0; 1, local scores 2 ½À1; 1), and the identity in distribution cannot be proved either, a higher weight score does not imply higher importance. Nevertheless, when used alone, the global scores have better prediction performance than local scores ( Supplementary Fig. S3A ). This result indicates that global score is marginally more important than local scores in the feature selection process.
The support from CCLE and Project Achilles made the DREAM challenge and this study possible. However, the Achilles gene essentiality scores obtained by the loss-of-function screen were noisy in nature, as shRNA experiments could involve incomplete knockdown and nonspecific or off-target knockdowns (Svoboda, 2007) . Our algorithm has the potential to improve its performance by integrating data from separate resources, such as data generated by CRISPR-Cas9 technology, to compensate for the noise (Smith et al., 2017) . In particular, the study of the driver genes (epi-drivers) that are not mutated in their DNA sequence, but their epigenetic changes control the metastatic status of cells (Chatterjee et al., 2017) , will require additional datasets and algorithms to predict, which is a promising future research direction.
